These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 16466123)

  • 1. Effect of ciprofloxacin and levofloxacin on the QT interval: is this a significant "clinical" event?
    Makaryus AN; Byrns K; Makaryus MN; Natarajan U; Singer C; Goldner B
    South Med J; 2006 Jan; 99(1):52-6. PubMed ID: 16466123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of three fluoroquinolones on QT interval in healthy adults after single doses.
    Noel GJ; Natarajan J; Chien S; Hunt TL; Goodman DB; Abels R
    Clin Pharmacol Ther; 2003 Apr; 73(4):292-303. PubMed ID: 12709719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of three fluoroquinolones on QT analysis after standard treatment courses.
    Tsikouris JP; Peeters MJ; Cox CD; Meyerrose GE; Seifert CF
    Ann Noninvasive Electrocardiol; 2006 Jan; 11(1):52-6. PubMed ID: 16472283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ciprofloxacin does not Prolong the QTc Interval: A Clinical Study in ICU Patients and Review of the Literature.
    Heemskerk C; Woldman E; Pereboom M; Van der Hoeven R; Mantel-Teeuwisse A; Van Gemeren C; Becker ML
    J Pharm Pharm Sci; 2017; 20(1):360-364. PubMed ID: 29145929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring the effects of supratherapeutic doses of levofloxacin on healthy volunteers using four methods of QT correction and periodic and continuous ECG recordings.
    Noel GJ; Goodman DB; Chien S; Solanki B; Padmanabhan M; Natarajan J
    J Clin Pharmacol; 2004 May; 44(5):464-73. PubMed ID: 15102866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of the QTc interval over a 24-h dose interval after start of intravenous ciprofloxacin or low-dose erythromycin administration in ICU patients.
    Berger FA; van Weteringen W; van der Sijs H; Hunfeld NGM; Bunge JJH; de Groot NMS; van den Bemt PMLA; van Gelder T
    Pharmacol Res Perspect; 2021 Dec; 9(6):e00865. PubMed ID: 34697899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of combined fluoroquinolone and azole use on QT prolongation in hematology patients.
    Zeuli JD; Wilson JW; Estes LL
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1121-7. PubMed ID: 23229485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QTc abnormalities in deliberate self-poisoning with moclobemide.
    Downes MA; Whyte IM; Isbister GK
    Intern Med J; 2005 Jul; 35(7):388-91. PubMed ID: 15958107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rates of torsades de pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin.
    Frothingham R
    Pharmacotherapy; 2001 Dec; 21(12):1468-72. PubMed ID: 11765299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of QTc Interval during Levofloxacin Prescription in Cardiac Patients with Pneumonia.
    Shojaei L; Ruzbahani M; Khajavian S; Shahsavari S; Tamasoki N; Rajabian M; Moradi F; Shahbazi F
    Curr Drug Saf; 2020; 15(2):111-116. PubMed ID: 32053078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Literature review and pilot studies of the effect of QT correction formulas on reported beta2-agonist-induced QTc prolongation.
    Milic M; Bao X; Rizos D; Liu F; Ziegler MG
    Clin Ther; 2006 Apr; 28(4):582-90. PubMed ID: 16750469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ciprofloxacin-induced acquired long QT syndrome.
    Prabhakar M; Krahn AD
    Heart Rhythm; 2004 Nov; 1(5):624-6. PubMed ID: 15851230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QTc-interval prolongation associated with slow intravenous erythromycin lactobionate infusions in critically ill patients: a prospective evaluation and review of the literature.
    Tschida SJ; Guay DR; Straka RJ; Hoey LL; Johanning R; Vance-Bryan K
    Pharmacotherapy; 1996; 16(4):663-74. PubMed ID: 8840374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QTc prolongation during ciprofloxacin and fluconazole combination therapy: prevalence and associated risk factors.
    Berger FA; Monadian N; de Groot NMS; Santbergen B; van der Sijs H; Becker ML; Broers AEC; van Gelder T; van den Bemt PMLA
    Br J Clin Pharmacol; 2018 Feb; 84(2):369-378. PubMed ID: 29057492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QTc prolongation associated with combination therapy of levofloxacin, imipramine, and fluoxetine.
    Nykamp DL; Blackmon CL; Schmidt PE; Roberson AG
    Ann Pharmacother; 2005 Mar; 39(3):543-6. PubMed ID: 15687478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A risk-benefit assessment of levofloxacin in respiratory, skin and skin structure, and urinary tract infections.
    Martin SJ; Jung R; Garvin CG
    Drug Saf; 2001; 24(3):199-222. PubMed ID: 11347723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QT prolongation and torsade de pointes induced by fluoroquinolones: infrequent side effects from commonly used medications.
    Briasoulis A; Agarwal V; Pierce WJ
    Cardiology; 2011; 120(2):103-10. PubMed ID: 22156660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of effect of perampanel on QT interval duration: Results from a thorough QT analysis and pooled partial seizure Phase III clinical trials.
    Yang H; Laurenza A; Williams B; Patten A; Hussein Z; Ferry J
    Epilepsy Res; 2015 Aug; 114():122-30. PubMed ID: 26088895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QT interval prolongation and risk of life-threatening arrhythmias during toxoplasmosis prophylaxis with spiramycin in neonates.
    Stramba-Badiale M; Nador F; Porta N; Guffanti S; Frediani M; Colnaghi C; Grancini F; Motta G; Carnelli V; Schwartz PJ
    Am Heart J; 1997 Jan; 133(1):108-11. PubMed ID: 9006298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical toxicologists' practice patterns regarding drug-induced QT prolongation in overdose patients: a survey in the United States of America, Europe, and Asia Pacific region.
    Othong R; Devlin JJ; Kazzi ZN
    Clin Toxicol (Phila); 2015 May; 53(4):204-9. PubMed ID: 25706450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.